Pharmacologic therapies after myocardial infarction

E Rapaport, M Gheorghiade - The American journal of medicine, 1996 - Elsevier
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

[引用][C] Pharmacologic therapies after myocardial infarction. Discussion

E RAPAPORT, M GHEORGHIADE… - … American journal of …, 1996 - pascal-francis.inist.fr
Pharmacologic therapies after myocardial infarction. Discussion CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Pharmacologic therapies after myocardial infarction.

E Rapaport, M Gheorghiade - The American Journal of Medicine, 1996 - europepmc.org
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

Pharmacologic Therapies After Myocardial Infarction

E Rapaport, M Gheorghiade - The American Journal of Medicine, 1996 - infona.pl
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

Pharmacologic therapies after myocardial infarction

E Rapaport, M Gheorghiade - American Journal of …, 1996 - scholars.northwestern.edu
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

Pharmacologic therapies after myocardial infarction

E Rapaport, M Gheorghiade - The American Journal of Medicine, 1996 - amjmed.com
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

Pharmacologic therapies after myocardial infarction

E Rapaport, M Gheorghiade - The American journal of …, 1996 - pubmed.ncbi.nlm.nih.gov
Despite the availability and use of effective methods for limiting infarct size with thrombolytic
agents and primary angioplasty, patients experiencing a myocardial infarction (MI) are at …

[引用][C] Pharmacologic therapies after myocardial infarction. Discussion

E RAPAPORT, M GHEORGHIADE… - The American journal of …, 1996 - Elsevier